XENICAL 120 mg Capsule Case of 84

Xenical or Orlistat is indicated in combination with a mildly hypocaloric diet in the treatment of obesity (body mass index (BMI) greater than or equal to 30 kg/m2) or overweight (BMI greater than or equal to 28 kg/m2) associated risk factors.

Treatment with Orlistatshould be discontinued after 12 weeks if patients have not lost at least 5% of initial weight measured at the beginning of treatment.

Therapeutic Class Metabolism and Nutrition
Active : Orlistat
Excipients Capsule content: microcrystalline cellulose (E460), starch, povidone (E1201), Sodium lauryl sulfate (E487), Talc (E553b), Walls Capsule: Gelatin, Indigo Carmine (E132), Titanium dioxide (E171),
Ink Printing Food: Iron oxide (E172), ammonium hydroxide (E528), Potassium hydroxide (E525), Shellac (E904)
Medicinal product subject to medical prescription
Laboratoire Roche Registration Ltd.
Read more…